An unexpected complication of prophylactic enoxaparin in an adolescent female
DOI:
https://doi.org/10.58877/japaj.v1i2.47Keywords:
Pediatric, enoxaparin, prophylaxis, intracranial hemorrhage, pediatric, Pediatric Critical CareReferences
Goudie A, Dynan L, Brady PW, Fieldston E, Brilli RJ, Walsh KE. Costs of Venous Thromboembolism, Catheter-Associated Urinary Tract Infection, and Pressure Ulcer. United States: American Academy of Pediatrics; 2015;136:432–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26260712
Monagle P, Cuello CA, Augustine C, Bonduel M, Brandão LR, Capman T, et al. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. United States: Elsevier Inc; 2018;2:3292–316. Available from: https://dx.doi.org/10.1182/bloodadvances.2018024786
Bennett E, Delgado-Corcoran C, Pannucci CJ, Wilcox R, Heyrend C, Faustino EV. Outcomes of Prophylactic Enoxaparin Against Venous Thromboembolism in Hospitalized Children. United States; 2022;12:617–25. Available from: https://www.ncbi.nlm.nih.gov/pubmed/35531629
Heit JA. Epidemiology of venous thromboembolism. England; 2015;12:464–74. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26076949
Mahajerin A, Croteau SE. Epidemiology and Risk Assessment of Pediatric Venous Thromboembolism. Switzerland: Frontiers Research Foundation; 2017;5:68. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28443269
Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. United States: American College of Chest Physicians; 2012;141:e195S-e226S. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22315261
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 JAP Academy Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.